GC Genome Study Pinpoints ‘Confounders’ Disrupting Cancer Signals to Enhance Liquid Biopsy Precision
YONGIN, South Korea, Dec. 9, 2025 — GC Genome, a leading clinical genomics and liquid biopsy company, announced that its research analyzing cell-free DNA (cfDNA) fragmentation patterns in 1,154 healthy...
